External
DSU Bulletins

1234567

Rehabilitation & Entitlements Policy Group

Intranet site:  http://sharepoint/servingourcustomers/compensation/dsu

#

28 March, 2011

THE FOLLOWING RMA SOPS ARE TO TAKE EFFECT ON 30 MARCH, 2011

New SOPs

Acute rheumatic fever

Revocations & Replacements

Rheumatic heart disease

Dental malocclusion

Malignant neoplasm of the liver

Amendments

Nil

Revocation

Metatarsalgia

NOTEWORTHY FEATURES

Acute rheumatic fever

New  – 23 & 24 of '11

  • This new SOP covers an autoimmune disease that may develop after a streptococcal throat infection. It occurs mostly in children and is now rare in western countries.  The condition causes inflammation of the joints, heart, skin and brain, often resulting in a severe illness requiring hospitalisation. Onset is typically around three weeks after the infection.  Some symptoms may persist for months.  The chronic heart valve problems that develop in a minority of people who've had rheumatic fever are covered by the rheumatic heart disease SOP.

Rheumatic heart disease

Revocation – 19 & 20 of '11

Replaces 93 and 94 of '95

Dental malocclusion

Revocation – 17 & 18 of '11

Replaces 372 and 373 of '95

  • The definition has been reworded but the SOP coverage is unchanged.
  • The previous factors for craniofacial injury and disease have now been restricted to maxillofacial injury and disease.
  • New onset and worsening factors have been added for: loss of teeth (as specified); having an adjacent odontogenic or ossifying fibroma; and using a mandibular repositioning device (for snoring or sleep apnoea) as specified.

Malignant neoplasm of the liver

Revocation – 21 & 22 of '11

Replaces 171 and 172 of '96

  • The onset factors from the old SOP have been retained, with some modifications.  The alcohol doses have been reduced from 150 kg to 110 kg for RH and from 220 kg to 150 kg for BOP.  The smoking cessation period has been increased from 10 to 20 years (RH & BOP).  The aflatoxins factor has been reworded.
  • There are 13 new onset factors in the RH SOP and seven new onset factors in the BOP SOP.  These new factors cover: ionising radiation; thorotrast; type 2 diabetes; obesity; oral contraceptive pill use; gaseous vinyl chloride exposure (all RH and BOP); steatohepatitis; anabolic steroid use; immunosuppressive drugs; HIV infection; chewing betel quid or areca nut; and arsenic exposure (all RH only).

Metatarsalgia

Revokes 39 and 40 of '96

  • These SOPs have been revoked and not replaced.  The RMA has concluded that metatarsalgia is not a disease or injury (it's a symptom).  This is the first time the RMA has revoked and not replaced a SOP.
  • Metatarsalgia can be a symptom of a number of diseases or injuries, including the disease Morton's metatarsalgia, for which SOPs were recently issued (92 & 93 of '10).
  • If metatarsalgia is claimed, the disease or injury that is the cause of the symptom should be established and that condition should be determined (using the appropriate SOP, if there is one).

Contact Officers for this bulletin:

Dr Jon Kelley48412

Dr Edwin Nicoll48583

# 3D echocardiogram of rheumatic mitral stenosis